Biosimilar
Third Biosimilar to Bevacizumab Approved
The FDA approved bevacizumab-maly (Alymsys, Amneal Pharmaceuticals), a biosimilar to bevacizumab (Avastin, ...
APRIL 19, 2022
The Case for Switching to Rituximab Biosimilar
Switching from originator rituximab to rituximab-abbs can save an institution up to $13,000 annually per patient ...
FEBRUARY 16, 2022
FDA Approves Riabni, Third Biosimilar to Rituxan
The FDA Approved Amgen's Riabni, the 3rd biosimilar to the originator, U.S.-licensed Rituxan.
DECEMBER 18, 2020
FDA Approves Ziextenzo Pegfilgrastim Biosimilar
Each year in the United States, more than 60,000 patients with cancer are hospitalized with evidence of ...
NOVEMBER 5, 2019
FDA Approves Pfizer Biosimilar to Rituxan
The FDA approved rituximab-pvvr (Ruxience, Pfizer), a biosimilar to rituximab (Rituxan, Genentech), for several ...
JULY 25, 2019
FDA Approves Ontruzant, Biosimilar to Herceptin
The biosimilar trastuzumab-dttb (Ontruzant, Samsung Bioepis) was approved for all eligible indications of the ...
JANUARY 22, 2019
FDA Approves Herzuma for Breast Cancer
The FDA approved Herzuma, a HER2/neu receptor antagonist biosimilar to Herceptin for breast cancer treatment.
DECEMBER 17, 2018
FDA Approves Truxima, First Biosimilar to Rituxan
The FDA approved rituximab-abbs (Truxima, Celltrion/Teva), the first biosimilar to rituximab (Rituxan, ...
DECEMBER 1, 2018
FDA Approves Nivestym, Second Biosimilar of Neupogen
The FDA approved Pfizer's Nivestym, a biosimilar of Neupogen for all eligible indications as the reference ...
JULY 25, 2018
FDA Approves Fulphila, First Biosimilar to Neulasta
Mylan's Fulphila is the first biosimilar to Neulasta to decrease the chance of infection as suggested by febrile ...
JUNE 6, 2018
First Epoetin alfa Biosimilar Receives FDA Approval for Anemia
Retacrit is the first U.S. biosimilar erythropoiesis-stimulating agent. Although not listed as an interchangeable ...
MAY 21, 2018
FDA Approves Biosimilar Ogivri for Breast, Stomach Cancers
Ogivri is the first biosimilar approved in the United States for the treatment of breast cancer or stomach ...
DECEMBER 4, 2017
